Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Clinical and Experimental Nephrology|February 19, 2014
Dyslipidemia and progression of kidney disease: role of lipid-lowering drugsVito M CampeseNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2017
Con: Mesoamerican nephropathy: is the problem dehydration or rehydration?Vito M CampeseSeminars in Nephrology|November 23, 2014
Pathophysiology of resistant hypertension in chronic kidney diseaseVito M CampeseClinical Nephrology|December 10, 2020
The unresolved epidemic of chronic kidney disease of uncertain origin (CKDu) around the world: A review and new insightsVito M CampeseClinical and Experimental Nephrology|October 31, 2003
A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implicationsVito M CampeseKidney International Supplements|January 25, 2019
Electrophysiological and clinical consequences of hyperkalemiaVito M Campese, Gbemisola AdenugaRecent Advances in Cardiovascular Drug Discovery|November 17, 2015
The Challenges of Blood Pressure Control in Dialysis PatientsVito M Campese, Ravi LakdawalaPediatric Nephrology (Berlin, Germany)|April 7, 2009
Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in childrenElaine Ku, Vito M CampeseThe Medical Clinics of North America|February 12, 2004
Evolving role of calcium antagonists in the management of hypertensionMurray Epstein, Vito M CampeseCurrent Hypertension Reports|May 11, 2002
Neurogenic factors in renal hypertensionVito M Campese, Ewa KrolPageof 5